Your browser doesn't support javascript.
loading
Sustained transmission over two decades of a previously unrecognised MPT64 negative Mycobacterium tuberculosis strain in Queensland, Australia: a whole genome sequencing study.
Bainomugisa, Arnold; Pandey, Sushil; O'Connor, Bridget; Syrmis, Melanie; Whiley, David; Sintchenko, Vitali; Coin, Lachlan J M; Marais, Ben J; Coulter, Christopher.
Affiliation
  • Bainomugisa A; Queensland Mycobacterium Reference Laboratory, Brisbane, Queensland, Australia.
  • Pandey S; Queensland Mycobacterium Reference Laboratory, Brisbane, Queensland, Australia.
  • O'Connor B; Public Health Intelligence Branch, Department of Health, Brisbane, Queensland, Australia.
  • Syrmis M; Queensland Mycobacterium Reference Laboratory, Brisbane, Queensland, Australia.
  • Whiley D; University of Queensland Centre for Clinical Research, Brisbane, Queensland, Australia.
  • Sintchenko V; Centre for Infectious Diseases and Microbiology-Public Health, Westmead Hospital, Western Sydney Local Health District, Sydney, New South Wales, Australia.
  • Coin LJM; NSW Mycobacterium Reference Laboratory, Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, NSW Health Pathology - Western, Sydney, New South Wales, Australia.
  • Marais BJ; Sydney Infectious Diseases Institute (Sydney ID), The University of Sydney, Sydney, New South Wales, Australia.
  • Coulter C; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia.
Lancet Reg Health West Pac ; 47: 101105, 2024 Jun.
Article in En | MEDLINE | ID: mdl-39022748
ABSTRACT

Background:

MPT64 is a key protein used for Mycobacterium tuberculosis (MTB) complex strain identification. We describe protracted transmission of an MPT64 negative MTB strain in Queensland, Australia, and explore genomic factors related to its successful spread.

Methods:

All MPT64 negative strains identified between 2002 and 2022 by the Queensland Mycobacteria Reference Laboratory, and an additional 2 isolates from New South Wales (NSW), were whole genome sequenced. Bayesian modelling and phylogeographical analyses were used to assess their evolutionary history and transmission dynamics. Protein structural modelling to understand the putative functional effects of the mutated gene coding for MPT64 protein was performed.

Findings:

Forty-three MPT64 negative isolates were sequenced, belonging to a single MTB cluster of Lineage 4.1.1.1 strains. Combined with a UK dataset of the same lineage, molecular dating estimated 1990 (95% HPD 1987-1993) as the likely time of strain introduction into Australia. Although the strain has spread over a wide geographic area and new cases linked to the cluster continue to arise, phylodynamic analysis suggest the outbreak peaked around 2003. All MPT64 negative strains had a frame shift mutation (delAT, p.Val216fs) within the MPT64 gene, which confers two major structural rearrangements at the C-terminus of the protein.

Interpretation:

This study uncovered the origins of an MPT64 negative MTB outbreak in Australia, providing a richer understanding of its biology and transmission dynamics, as well as guidance for clinical diagnosis and public health action. The potential spread of MPT64 negative strains undermines the diagnostic utility of the MPT64 immunochromatographic test.

Funding:

This study was funded from an operational budget provided to the Queensland Mycobacterium Reference Laboratory by Pathology Queensland, Queensland Department of Health.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Lancet Reg Health West Pac Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Lancet Reg Health West Pac Year: 2024 Document type: Article Affiliation country: Country of publication: